Real-world evidence of quality of life improvement in patients with distal ulcerative colitis treated by mesalazine: the Quartz study.
European journal of gastroenterology & hepatology（2022）
摘要
HRQoL measuring with the SIBDQ is proportionally related to disease activity in patients with distal UC treated with mesalazine.
更多查看译文
关键词
ulcerative colitis,distal ulcerative colitis,mesalazine,life improvement,real-world
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要